Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Consulting agrmnt
Director departure
Appointed director
BioSig Technologies, Inc. (BSGM) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 D Form D - Notice of Exempt Offering of Securities:
09/27/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Warrant",
"Form of Laidlaw Warrant",
"Form of Securities Purchase Agreement"
09/27/2023 D Form D - Notice of Exempt Offering of Securities:
08/24/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals BioSig Technologies, Inc. , a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today is providing an update since the launch of BioSig’s established technology team with external partners and collaborators to advance the research and development of an artificial intelligence medical device platform. On July 20, 2023, we announced the inclusion of BioSig AI Sciences, Inc., a majority owned subsidiary of the Company , in Nvidia’s Inception partnership program, providing our team access to engineering and technology support. On July 23, 2023, BAIS completed its seed round of funding of $2.2 million. The fundin..."
08/23/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations"
08/22/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases Latest Software Release Supports Electrophysiologists with Visualizing Heart Patterns Difficult to Recognize with the Naked Eye Westport, CT, Aug. 22, 2023 -- BioSig Technologies, Inc. , a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today the release of new software features for the PURE EP™ Platform. The novel software features were successfully leveraged for the first time during patient cases conducted at the Kansas City Heart Rhythm Institute . Building on the FDA-cleared platform's proprietary combination of advanced hardware and software, PURE EP™'s latest software debuts two new features designed to harness t..."
08/18/2023 4 Weild IV David (Director) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 16,000 shares @ $0
08/18/2023 4 Klein James L (Director) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 16,000 shares @ $0
08/18/2023 4 Hrkac Frederick (Director) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 16,000 shares @ $0
08/18/2023 4 Gallagher Patrick Joseph (Director) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 12,000 shares @ $0
08/18/2023 4 FOLEY DONALD E (Director) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 16,000 shares @ $0
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2023 8-K Quarterly results
08/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 D Form D - Notice of Exempt Offering of Securities:
07/31/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
06/30/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Securities Purchase Agreement"
06/12/2023 4 LONDONER KENNETH L (CEO) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Bought 2,000 shares @ $1.1, valued at $2.2k
Bought 2,000 shares @ $1.22, valued at $2.4k
Bought 2,000 shares @ $1.2, valued at $2.4k
06/09/2023 4 LONDONER KENNETH L (CEO) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Bought 1,000 shares @ $1.56, valued at $1.6k
Bought 2,000 shares @ $1.55, valued at $3.1k
Bought 1,000 shares @ $1.57, valued at $1.6k
Bought 1,000 shares @ $1.58, valued at $1.6k
Bought 1,000 shares @ $1.59, valued at $1.6k
Bought 1,000 shares @ $1.6, valued at $1.6k
Bought 1,000 shares @ $1.32, valued at $1.3k
Bought 3,000 shares @ $1.37, valued at $4.1k
Bought 200 shares @ $1.43, valued at $286
Bought 400 shares @ $1.44, valued at $576
05/26/2023 D Form D - Notice of Exempt Offering of Securities:
05/19/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias"
05/09/2023 4 Sieckhaus John (COO) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 295,620 shares @ $0
05/09/2023 4 LONDONER KENNETH L (CEO) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 576,000 shares @ $0
05/09/2023 4 Fleming Gray (Chief Commercial Officer) has filed a Form 4 on BioSig Technologies, Inc.
Txns: Granted 295,620 shares @ $0
04/28/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Corporate Presentation dated April 2023 (furnished herewith pursuant to Item 7.01)",
"Corporate Summary dated April 2023 (furnished herewith pursuant to Item 7.01)"
04/28/2023 D Form D - Notice of Exempt Offering of Securities:
04/21/2023 8-K Quarterly results
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy